GeezerVison is showing www.rcsb.org — RCSB PDB - 2XSI: Human serum albumin complexed with dansyl-L-glutamate and myristic acid 2XSI | pdb_00002xsiHuman serum albumin complexed with dansyl-L-glutamate and myristic acid
Experimental Data Snapshot - Method: X-RAY DIFFRACTION
- Resolution: 2.70 Å
- R-Value Free:
0.251 (Depositor), 0.261 (DCC) - R-Value Work:
0.191 (Depositor), 0.207 (DCC) - R-Value Observed:
0.191 (Depositor)
Starting Model: experimental View more details This is version 1.4 of the entry. See complete history. Structural Basis of Binding of Fluorescent, Site-Specific Dansylated Amino Acids to Human Serum Albumin.Ryan, A.J., Ghuman, J., Zunszain, P.A., Chung, C.W., Curry, S.(2011) J Struct Biol 174: 84 - PubMed: 20940056 Search on PubMedSearch on PubMed Central
- DOI: https://doi.org/10.1016/j.jsb.2010.10.004
- Primary Citation Related Structures:
2XSI, 2XVQ, 2XVU, 2XVV, 2XVW, 2XW0, 2XW1
- PubMed Abstract:
Human serum albumin (HSA) has two primary binding sites for drug molecules. These sites selectively bind different dansylated amino acid compounds, which-due to their intrinsic fluorescence-have long been used as specific markers for the drug pockets on HSA. We present here the co-crystal structures of HSA in complex with six dansylated amino acids that are specific for either drug site 1 (dansyl-l-asparagine, dansyl-l-arginine, dansyl-l-glutamate) or drug site 2 (dansyl-l-norvaline, dansyl-l-phenylalanine, dansyl-l-sarcosine). Our results explain the structural basis of the site-specificity of different dansylated amino acids. They also show that fatty acid binding has only a modest effect on binding of dansylated amino acids to drug site 1 and identify the location of secondary binding sites. Organizational Affiliation: - Biophysics Section, Blackett Laboratory, Imperial College, Exhibition Road, London SW7 2AZ, United Kingdom.
Macromolecule Content - Total Structure Weight: 68.67 kDa
- Atom Count: 4,662
- Modeled Residue Count: 582
- Deposited Residue Count: 585
- Unique protein chains: 1
Small Molecules| Ligands 2 Unique |
|---|
| ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions |
|---|
9NE
Query on 9NE
Download:Ideal Coordinates CCD File
| H [auth A], I [auth A] | DANSYL-L-GLUTAMATE C17 H20 N2 O6 S OXWKCHDQOLCMPE-ZDUSSCGKSA-N |  | | MYR
Query on MYR
Download:Ideal Coordinates CCD File
- SDF format, chain B [auth A]
- SDF format, chain C [auth A]
- SDF format, chain D [auth A]
- SDF format, chain G [auth A]
- SDF format, chain F [auth A]
- SDF format, chain E [auth A]
- MOL2 format, chain B [auth A]
- MOL2 format, chain C [auth A]
- MOL2 format, chain D [auth A]
- MOL2 format, chain G [auth A]
- MOL2 format, chain F [auth A]
- MOL2 format, chain E [auth A]
- mmCIF format, chain B [auth A]
- mmCIF format, chain C [auth A]
- mmCIF format, chain D [auth A]
- mmCIF format, chain G [auth A]
- mmCIF format, chain F [auth A]
- mmCIF format, chain E [auth A]
| B [auth A] C [auth A] D [auth A] E [auth A] F [auth A]
B [auth A], C [auth A], D [auth A], E [auth A], F [auth A], G [auth A] | MYRISTIC ACID C14 H28 O2 TUNFSRHWOTWDNC-UHFFFAOYSA-N |  | |
Experimental Data & ValidationExperimental Data- Method: X-RAY DIFFRACTION
- Resolution: 2.70 Å
- R-Value Free: 0.251 (Depositor), 0.261 (DCC)
- R-Value Work: 0.191 (Depositor), 0.207 (DCC)
- R-Value Observed: 0.191 (Depositor)
Unit Cell: | Length ( Å ) | Angle ( ˚ ) |
|---|
| a = 189.26 | α = 90 | | b = 38.95 | β = 105.46 | | c = 95.39 | γ = 90 |
Software Package:| Software Name | Purpose |
|---|
| CNS | refinement | | MOSFLM | data reduction | | SCALA | data scaling | | CNS | phasing |
Entry History - Version 1.0: 2010-11-10
Type: Initial release
- Version 1.1: 2011-05-08
Changes: Version format compliance - Version 1.2: 2011-07-13
Changes: Version format compliance - Version 1.3: 2023-12-20
Changes: Data collection, Database references, Derived calculations, Other, Refinement description - Version 1.4: 2024-10-23
Changes: Structure summary
|